The FDA flagged a Hetero Labs drugmaking plant near Hyderabad, India for multiple violations of good manufacturing practice standards. Source: Drug Industry Daily

A federal judge shut down efforts by Eli Lilly to throw out a $20 million patent infringement verdict against the drugmaker. Source: Drug Industry Daily

A Pennsylvania district court refused to certify a group of corporate and institutional drug purchasers as plaintiffs in a class-action antitrust suit against several drugmakers — saying the approximately two-dozen…

The FDA revised its near-decade-old guidance on developing generic versions of digoxin tablets, calling for more robust testing. The agency reconsidered the guidance in response to a citizen petition from…